Phillip W. Gold

Potential Uses of Corticotropin‐Releasing Hormone Antagonists

G. Chrousos, K. Rice, P. Gold, 2006, Annals of the New York Academy of Sciences.

Multiple sclerosis is associated with alterations in hypothalamic-pituitary-adrenal axis function.

G. Chrousos, E. Sternberg, P. Gold, 1994, The Journal of clinical endocrinology and metabolism.

Sex differences in sensitivity of the hypothalamic-pituitary-adrenal axis.

A. Baum, G. Chrousos, P. Gold, 1993, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

Differences in the hypothalamic-pituitary-adrenal axis of black and white women.

G. Chrousos, S. Yanovski, J. Yanovski, 1993, The Journal of clinical endocrinology and metabolism.

The corticotropin-releasing hormone stimulation test: a possible aid in the evaluation of patients with adrenal insufficiency.

G. Chrousos, E. Oldfield, H. Schulte, 1984, The Journal of clinical endocrinology and metabolism.

The role of adipokines in the rapid antidepressant effects of ketamine

E. Ballard, D. Luckenbaugh, C. Zarate, 2017, Molecular Psychiatry.

Hypothalamic corticotropin-releasing hormone suppression during the postpartum period: implications for the increase in psychiatric manifestations at this time.

G. Chrousos, P. Gold, G. Mastorakos, 1996, The Journal of clinical endocrinology and metabolism.

Marked suppression of gastric ulcerogenesis and intestinal responses to stress by a novel class of drugs

G. Chrousos, E. Sternberg, K. Rice, 2002, Molecular Psychiatry.

Individual reactivity and physiology of the stress response.

G. Chrousos, P. Deuster, P. Gold, 2000, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.